EU regulator rejects Alzheimer's drug lecanemab – BBC.com

Business News

  1. EU regulator rejects Alzheimer’s drug lecanemab  BBC.com
  2. European committee says Alzheimer’s treatment Leqembi shouldn’t get marketing approval  The Associated Press
  3. Eisai, Biogen Alzheimer’s Drug Denied by European Regulators  Bloomberg
  4. EMA Refuses Marketing Authorization for Alzheimer’s Drug  Medscape
  5. European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai  CNBC

Source: Business News

/by